A Phase I, Healthy Volunteer Determination Of 5HT4 Receptor Occupancy Of PF-04995274, Using PET With Ligand [11C]PF-05127401.

Trial Profile

A Phase I, Healthy Volunteer Determination Of 5HT4 Receptor Occupancy Of PF-04995274, Using PET With Ligand [11C]PF-05127401.

Completed
Phase of Trial: Phase I

Latest Information Update: 31 May 2011

At a glance

  • Drugs PF 4995274 (Primary)
  • Indications Alzheimer's disease
  • Focus Pharmacokinetics
  • Most Recent Events

    • 31 May 2011 Status changed from recruiting to completed as reported by ClinicalTrials.gov
    • 15 Sep 2010 Actual initiation date added to 1 Aug 2010 as reported by ClinicalTrials.gov.
    • 15 Sep 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top